ROCKET PHARMACEUTICALS, INC. - 10-Q Filing
Rocket Pharmaceuticals, Inc. reports Q3 2025 financial results including research and development expenses and updates on debt facilities.
Tickers: $RCKT
Rocket Pharmaceuticals, Inc. reports Q3 2025 financial results including research and development expenses and updates on debt facilities.
Tickers: $RCKT